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Summary The prognostic significance of argyrophilic nucleolar organiser regions (AgNORs) has been
evaluated in biopsy specimens from 61 primary squamous and undifferentiated carcinomas of the pharynx
prior to therapy.
The univariate Kaplan-Meyer survival analysis showed a significant correlation between 3- and 5-year
survival rates and the mean AgNOR number per tumour cell (P<0.001). No significant correlation was found
between prognosis and patients age and sex, tumour location, clinical stage, histologic grade, extent of
lymphocytic infiltration, HMFG-2 positivity of tumour cells and UCHL1, LN2, MB2 positivity of infiltrating
lymphocytes. There was no significant association between AgNOR counts and tumour histologic grade or
clinical stage.
Multivariate survival analysis showed that only two variables were significantly correlated with prognosis:
AgNOR counts (P<0.001) and the extent of lymphocytic infiltration (P<0.027). Our results indicate the
prognostic value of AgNOR counts and suggest the use of this method as a significant parameter in the
pretherapeutic assessment of the aggressiveness of pharyngeal carcinomas.
The analysis of nucleolar organiser regions (NORs), loops of
DNA which transcribe to ribosomal RNA (Gall & Pardue,
1969), has been recently introduced in surgical pathology.
Different NOR patterns give information about nucleolar
structure and activity in hyperplastic and neoplastic condi-
tions (Walker, 1988) and may be useful for distinguishing
benign and malignant cells. Small size, large number and
scattered distribution of NORs are characteristic of malig-
nant tumours; large size, small number and clustered distri-
bution are characteristic of benign tumours (Crocker & Nar,
1987; Crocker & Skilbeck, 1987; Derenzini et al., 1988; Smith
& Crocker, 1988). This technique allows also retrospective
studies, as proteins associated with NORs can be detected by
a simple one-step argyrophilic technique (AgNOR staining),
even in routinely fixed and paraffin wax-embedded tissue
sections (Ploton et al., 1986).
Interest in this method has recently increased since a cor-
relation between AgNOR content and prognosis has been
observed in neuroblastoma (Egan et al., 1988b), prostatic
cancer (Contractor et al., 1989), breast carcinomas (Sivridis
& Sims, 1990) and colorectal carcinomas (Ofner et al., 1990;
Riischoff et al., 1990).
Another histopathological feature which has been associat-
ed with the prognosis of malignant tumours is the lymphoid
stromal infiltration (Underwood, 1974): carcinomas of the
larynx and hypopharynx with heavy lymphocyte infiltrates
have a better prognosis (Bennett et al., 1971); particularly a
high number of intratumoural T-lymphocytes was found to
be a good prognostic sign (Shimokawara et al., 1982; Cohen
et al., 1987).
The expression of tumour-associated antigens has also
been associated with survival. HMFG-2, a monoclonal anti-
body which detects a glycoprotein of the cell membrane
(Taylor-Papadimitriou et al., 1981), has been used for prog-
nostic studies in cancer of the larynx (Cortesina et al., 1989)
and pharynx (Navone et al., 1989).
The aim of this work was to examine the prognostic
significance of AgNOR counts in sections of routinely pro-
cessed biopsy specimens from 61 primary squamous and
undifferentiated carcinomas of the pharynx, retrospectively
studied, prior to any curative treatment. The histologic grade
and clinical stage of the tumours were compared with
AgNOR expression. The prognostic importance of AgNOR
counts in relation to various clinical (age, sex, tumour loca-
tion and clinical stage) and morphological parameters (histo-
logic grade, lymphocytic infiltration, immunohistochemical
characteristics of neoplastic and reactive cells) was then
tested by means of uni- and multivariate survival analyses.
Materials and methods
The study was performed in 61 patients who underwent
biopsy for pharyngeal carcinoma. Ten were females, 51
males. The mean age was 59.4 year (29-85). Twenty-four
carcinomas were from oropharynx, 19 from hypopharynx
and 18 from nasopharynx. The cases were classified accord-
ing WHO (Shanmugaratnam & Sobin, 1978) and histopatho-
logically graded and clinically staged according to UICC
(Hermanek & Sobin, 1987). All cases were squamous carcin-
omas, except 12 undifferentiated nasopharyngeal carcinomas:
33 were grade II and 28 grade III; 10 were stage TI, 21 T2,
18 T3 and 12 T4; 32 were NO, 8 NI, 2 N2 and 19 N3.
The 18 nasopharyngeal carcinomas were classified as
squamous (six cases) and undifferentiated carcinomas (12
cases); the latters were considered as grade III carcinomas.
After diagnosis, all the patients have been treated with
external radiotherapy alone. The radiotherapy was performed
with Co6O with two lateral opposite fields directed to the
primary tumour and latero-cervical superior and medial
lymph node chains; an anterior field encompassing the
inferior latero-cervical and supraclavear lymph node chains
was also performed. In the rhinopharyngeal localisation 1/3
of the dosage was supplied by an anterior field.
A minimum follow-up of 3 years or to a patient's death
was available for all the cases.
Tissue processing
Surgical biopsies were immediately fixed in 10% formol for
24 h and embedded in paraffin; 3 p thick sections were cut
for histological and AgNOR staining; 31 thick sections
mounted on 0.01% poly-L-lysine coated slides and dried
overnight at 56°C were used for immunohistochemistry.
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Histology
Hematoxylin-Eosin, PAS and Giemsa staining were perform-
ed. The lymphocytic infiltration was evaluated as heavy
( + + + ) or mild ( + ) if more or less than 15 lymphocytes
per 400 x field were observed.
AgNOR staining
Sections were cut, dewaxed in xylene and ethanol and then
rehydrated. AgNOR staining was done using a solution con-
sisting of one volume of 2% gelatin in 1% aqueous formic
acid and two volumes of 50% silver nitrate. Silver staining
was performed at 37°C for 8-10 min. Slides were counter-
stained with methyl-green and mounted in DPX (BDH
Chemicals, Poole, UK).
Evaluation ofAgNOR numbers
In each specimen, random fields were examined using a
100 x oil immersion lens. Black dots within nuclei from 200
tumour cells were counted. Single AgNORs and individual
AgNORs within clumps where counted by careful focusing
through the whole thickness of the section. When large
polycyclic structures (overlapping NORs) where observed,
they were counted as a single AgNOR if individual AgNORs
could not be identified. The mean number of AgNORs per
nucleus in each case was calculated.
Immunohistochemistry
Immunostaining was performed by the ABC method (Hsu et
al., 1981). Sections were dewaxed, rehydrated and brought to
phosphate-buffered saline. Endogenous peroxidase activity
was blocked by incubation for 30 min in methanol with 0.5%
H202.
Monoclonal antibodies against HMFG-2 (kindly supplied
by Dr J. Taylor-Papadimitriou), against B lymphocytes
(LN2, MB2 from Biotest Clonab°) and T lymphocytes
(UCHL1 from Dakopatts°) were used. LN2 and MB2 were
diluted 1:2, UCHLI was diluted 1:200, HMFG-2 was diluted
in PBS at a concentration of 10,tg ml-'; all antisera were
incubated overnight. Normal mouse serum was substituted
for primary antibodies as a negative control. The sections
were then incubated for 30 min with biotin-labelled second
layer antibody and avidin-biotin-peroxidase complex (Dako-
patts0) was added. Sections were developed with diaminoben-
zidine for 10 min, counterstained with hematoxylin and
mounted in DPX (BDH Chemicals, Poole, UK).
The percentage of UCHL1, LN2, MB2 positive lympho-
cytes in the infiltrate and of neoplastic cells stained by
HMFG-2 antibody was determined by counting the positive
cells and the unreactive cells at a magnification of 400 x.
Five different areas were selected for evaluating the HMFG-2
positive cells (about 200 cells). From five to 15 different
areas, according to the extent of the lymphocytic infiltrate,
were selected for assessing the immunophenotype of lympho-
cytes (about 100 positive cells).
Statistical analysis
Association between AgNOR scores, and tumour histological
grade and/or clinical stage was estimated by one-way analysis
of variance (ANOVA).
Univariate survival analyses were based on the Kaplan-
Meier product-limit estimates of survival distribution (Kap-
lan & Meier, 1958).
Differences between survival curves were tested statistically
using the generalised Wilcoxon test (Gehan, 1965). The rela-
tive importance of multiple prognostic factors on survival
was estimated using the Cox proportional hazards regression
model (Cox, 1972).
All data were processed with BMDP statistical software
produced by Health Science Computing Facility, UCLA
(BMPD, 1981).
Results
Relationship between AgNOR number andpharyngeal
carcinoma grade or stage
In all cases of pharyngeal carcinoma, tumour cells contained
numerous dot-like AgNORs often of different size and shape
(Figure 1). Few large irregular granules were formed ofmany
small AgNORs (five or more) and were mainly located in the
nucleoli; many small single 'dots' were also dispersed in the
nucleus. Careful focusing was necessary to identify small single
dots within blebs. The results are summarised in Table I.
Even though the mean number of AgNORs per cell was
higher in more advanced (T4) stage carcinomas (Figure 2),
the ANOVA showed no significant association between
AgNOR number and histologic grade (P = 0.08), T stage
(P = 0.18) and N status (P = 0.9).
Figure 1 G2 pharyngeal carcinoma stained by AgNOR techni-
que. Small number and clustered distribution of NORs are visi-
ble. Original magnification x 1950.
Table I AgNORs/cell in pharyngeal carcinomas
Mean Median SD Min-Max value P
All cases (n = 61) 10.7 10.3 1.9 7.31-15.5
Grade II (n = 33) 11.1 10.55 2.02 7.31-15.5
Grade III (n = 28) 10.27 10.08 1.68 7.94-14.08 n.s.
StageTI (n= 10) 11.18 11.19 1.84 8.18-13.36
Stage T2 (n = 21) 10.08 10.08 1.55 7.94-14.08
Stage T3 (n = 18) 10.68 10.6 2.05 7.31-14.11 n.s.
Stage T4 (n= 12) 11.47 10.6 2.16 8.69-15.5
Stage NO (n = 32) 10.6 10.32 2 7.94-15.5
Stage NI (n = 8) 11.07 10.67 1.81 8.79-13.23
Stage N2 (n = 2) 10.25 10.22 0.19 10.09-10.36 n.s.
Stage N3 (n= 19) 10.82 10.3 1.95 7.31-14.11
Figure 2 T4 pharyngeal carcinoma shows large number and
scattered distribution of AgNORs. Original magnification x 1150.AGNORs AND PROGNOSIS IN PHARYNGEAL CARCINOMA 329
Univariate survival analysis
The overall 3 and 5 year survivals rates were 51% and 44%.
The median of the survival was 36 months (3-132). The
number of AgNOR per cell strongly correlated with the
patients outcome at 3-5 year follow-up (P< 0.001) (Table II
and Figure 3). The median of survival for cases with < 10.31
NOR/cell was 57 months; for cases with > 10.31 NOR/cell it
was 20 months.
Hypopharyngeal carcinomas had the worst prognosis (5
year survival rate of 32% vs 49% of oropharyngeal and 52%
of rhinopharyngeal). T4 stage cases had a 5 year survival rate
of 25% vs 40-52% of the other stages. N3 patients had a 5
year survival rate of 30% vs 52-62% of NO and NI. The 5
year survival for G2 carcinomas (40%) was worse than that
of G3 carcinomas (52%); these differences however were not
statistically significant. The extent of the lymphocytic infil-
trate and the immunophenotype of the infiltrating lympho-
cytes did not significantly correlate with prognosis: cases with
mild lymphocytic infiltrate had a 5 year survival rate of
52.5% vs 42% for cases with heavy lymphocytic infiltration
(P = 0.76); cases with many UCHL-1 positive T lymphocytes
had a 5 year survival rate of 50% vs 40% for cases with few
lymphocytes (P = 0.54); cases with relatively numerous LN2,
MB2 positive B lymphocytes showed a 5 year survival rate of
50% vs 42-45% for cases with few B lymphocytes (P = 0.43;
P = 0.47). Carcinomas with more than 50% of HMFG-2
positive neoplastic cells had a 5 year survival rate of 40% vs
52% for cases with a lesser HMFG-2 positivity (P = 0.29).
Patients age and sex were also not significantly correlated
with prognosis, even though the 5 year survival rate was
better in females (59%) than in males (42%) (P = 0.16) and
in the older age group (50%) than in the younger group
(42%) (P = 0.76) (Table III).
When the 18 nasopharyngeal carcinomas were separately
analysed, none of the previous parameter significantly cor-
related with prognosis. The 5 year survival rate for cases with
< 10.31 NOR/cell was 70% vs 20% for cases with > 10.31
NOR/cell. However the significance of AgNOR counts was
limited to 10% (Mantel-Cox Test = 2.77; P = 0.09). When
the remaining 43 oro-hypopharyngeal carcinomas were separ-
ately analysed, the only significant prognostic parameters was
the AgNOR counts: cases with < 10.31 NOR/cell had a 5
year survival rate of 67% vs 17% for cases with > 10.31
NOR/cell (P = 0.0001).
Multivariate survival analysis
To determine if AgNOR count was an independent prognos-
tic variable in pharyngeal carcinoma, a multivariate analysis
Table II Correlation of AgNOR count and 3-5 year survival in
pharyngeal carcinoma (n = 61)
3 year survival 5 year survival
No. rate (%) rate (%) P
No AgNOR < 10.31 31 77 68 <0.001
/cell > 10.31 30 30 20
CD
.c
c' 0.8
c
0
t 0.6 0
0. 0
a 0.4
X 0.2
3 0 0 0
Figure 3 Kaplan-Meier survival curves for pharyngeal car-
cinoma with values: < 10.31 and > 10.31 AgNOR/nucleus.
was performed. By testing the association of response with
covariates in the Cox model, only two variables showed
significant correlation with prognosis in the whole series:
AgNOR counts (P<0.001) and, to a lesser degree, the extent
of the lymphocytic infiltration (P = 0.027). The multivariate
survival analysis of the 18 nasopharyngeal carcinomas,
separately evaluated, showed a high significance of the
covariate AgNOR counts (P= 0.007); the extent of the lym-
phocytic infiltration was also significant (P = 0.018). The
multivariate survival analysis of the remaining 43 oro-hypo-
pharyngeal carcinomas indicated the AgNOR counts as the
only significant parameter (P<0.001) (Table IV).
Discussion
The AgNOR analysis of our pharyngeal carcinomas is in line
with the results obtained in non-Hodgkin's lymphomas
(Crocker & Nar, 1987), melanocytic lesions (Crocker &
Skilbeck, 1987), epithelial tumours of human intestine
(Derenzini et al., 1988) and breast tumours (Smith &
Crocker, 1988). In fact the most differentiated pharyngeal
carcinomas showed a relatively large size and clustered distri-
bution of NORs, while the less differentiated carcinomas
showed small size and scattered distribution of NORs.
Table III Correlation of age, sex, morphologic parameters and 3-5
year survival time in pharyngeal carcinoma (n = 61)
3 year survival 5 year survival
Variable No. rate (%) rate (%) P
Age . 59 31 55 42 0.76
>59 30 52 50
Sex F 10 69 59 0.16
M 51 49 42
Location
Oropharynx 24 49 49
Rhinopharynx 18 77 52 0.22
Hypopharynx 19 37 32
Histologic G2 33 42 40 0.37
grade G3 28 64 52
TI 10 50 40
T Stage T2 21 62 52
T3 18 55 50 0.203
T4 12 25 25
NO 32 55 52
N Stage NI 8 62 62
N2 2 50 0 0.73
N3 19 47 30
Lymphocytic + + + 40 52.5 42 0.76
infiltration + 21 52.5 52.5
UCHL1 pos. > 70% 34 54 50 0.54
lymphocytes <70% 27 52 40
MB2 pos. > 10% 14 64 50 0.43
lymphocytes < 10% 47 50 45
LN2 pos. > 10% 28 52 50 0.47
lymphocytes < 10% 33 47 42
HMFG2 pos. > 50% 35 45 40 0.29
carcinoma <50% 26 62 52
cells
Table IV Results of effective variables in multivariate analysis of
pharyngeal carcinomas. Cox model
Nasopharyngeal Oro-hypopharyngeal
All cases carcinomas carcinomas
(n =61) (n = 18) (n=43)
Variable Improvement Improvement Improvement
chi-square P chi-square P chi-square P
No AgNOR 30.820 <0.001 7.256 <0.01 30.178 <0.001
/cell
Lymphocytic 4.871 0.027 5.625 <0.02 n.s.
infiltration
15 30 45 60 75 90 105 120 135
Time (months)330 A. PICH et al.
But the mean NOR number/cell was not statistically different
in the various degrees of differentiation. Similar results have
been found in squamous tumours of the pharynx and larynx
(Bryan et al., 1989), in renal adenomas and carcinomas
(Bryan et al., 1990), in colorectal carcinomas (Riischoff et al.,
1990) and in renal cell carcinomas (Pich et al., 1991).
We have not observed positive association between
AgNOR number and T or N stages in pharyngeal carcino-
mas, in accord with the findings of Ruschoff et al. (1990) in
colorectal carcinomas and of Pich et al. (1991) in renal cell
carcinomas, but in contrast with the results of Riischoff et al.
(1989) in renal carcinomas and Sivridis and Sims (1990) in
breast carcinomas. These conflicting results may be due to
the relatively low number of Ni and N2 carcinomas in our
series, to the lack of the pathological staging of our cases and
to the partly different methods of evaluation of the silver
staining. However, even though more sophisticated techni-
ques which could improve evaluation of AgNOR staining,
such as image analysis, have recently been applied to cyto-
logic and histologic preparations (Derenzini et al., 1989;
Ruschcoff et al., 1989; Ruschoff et al., 1990), our counting
procedure is substantially similar to the well established
method used by most authors (Crocker & Nar, 1987;
Crocker & Skilbeck, 1987; Derenzini et al., 1988; Smith &
Crocker, 1988; Bryan et al., 1990), that has always given
consistent and reproducible results.
We have clearly demonstrated that AgNOR count is an
important variable predicting survival in our series of
pharyngeal carcinomas. Even though the univariate survival
analysis of our cases of nasopharyngeal carcinomas showed a
significance of the AgNOR counts limited to 10%, the multi-
variate analysis demonstrated a high significance of the
covariate AgNOR (P<0.01): the discrepancy can be explain-
ed by the small number of cases (18) and events (eight
deaths). Moreover, the uni- and multivariate survival analysis
of the remaining 43 oro-hypopharyngeal carcinomas showed
that AgNOR count was the only significant parameter. This
result is in accordance with the data obtained in other types
of tumours: childhood neuroblastomas (Egan et al., 1988b),
prostatic cancer (Contractor et al., 1989) and colorectal car-
cinomas (Ofner et al., 1990; Ruschoff et al., 1990). The
prognostic significance of AgNOR counts may be due to
their correlation with cell proliferation: in non-Hodgkin's
lymphoma (Hall et al., 1988) and breast carcinomas (Dervan
et al., 1989) there is a clear correlation between AgNOR
staining and Ki67 immunostaining; cells positive for Ki67
have high AgNOR counts, while Ki67 negative cells contain
only one or two AgNORs (Murray et al., 1989); a linear
relationship was found between cell duplication activity and
the amount of AgNOR proteins in cell lines derived from
different tumour types (Derenzini et al., 1990). However, in
renal cell carcinomas such correlation is only slightly signi-
ficant (Pich et al., 1991) and in non-neoplastic tissues
AgNOR counts seem to reflect a ploidy rather than cell
proliferation (Suresh et al., 1990).
Our findings are in agreement with studies on a large series
of head and neck cancer, in which the labelling index, repre-
senting the percentage of proliferating cells, was highly relat-
ed with survival, while not correlated with tumour histologic
grade (Chauvel et al., 1989).
The correlation between the extent of lymphocytic infil-
tration and prognosis, observed in many malignant tumours
(Underwood, 1974), has failed to be clearly demonstrated in
our series of pharyngeal carcinomas. In fact the multivariate
survival analysis of the whole series showed a weak correla-
tion (P = 0.027) that was not confirmed by the univariate
survival analysis (P = 0.76). Since the Iymphocytic infiltrate
may be prominent in nasopharyngeal carcinomas, featuring
the s.c. 'Iymphoepithelioma', we have separately analysed the
extent of the infiltrate in our small series of nasopharyngeal
(18 cases) and oro-hypopharyngeal (43 cases) carcinomas. In
nasopharyngeal carcinomas the results were similar to those
of the whole series, with a more pronounced significance in
the multivariate analysis (P<0.02 vs P = 0.27), but the lym-
phocytic infiltrate was not significant in the uni- and multi-
variate analysis of the 43 oro-hypopharyngeal cases. This
lack of correlation is in accordance with the findings of
Shanmugaratnam et al. (1979) in nasopharyngeal carcinomas
and Goldsmith et al. (1987) in head and neck cancers. More-
over we did not observe a positive correlation (P = 0.54)
between high number of UCHL1 positive T lymphocytes and
prognosis, in the whole series as well as in naso- or oro-
hypopharyngeal cases, in contrast with the results of Shimo-
kawara et al. (1982) in human breast cancer and Cohen et al.
(1987) in disseminated carcinomas treated with Interleukin-2.
This may depend on the peculiarity of pharyngeal carcino-
mas: they arise in a territory rich of lymphoid tissue where
the infiltrating lymphocytes may be regarded as residual
rather than reactive.
The lack of correlation between the expression of HMFG-
2 and survival contrasts with the results of Cortesina et al.
(1989): but the series are not homogeneous, as their laryngeal
carcinomas have been treated also with surgery, while all our
pharyngeal carcinomas underwent radiotherapy alone.
In accord with Shanmugaratnam et al. (1979) and Hsu et
al. (1987) who found that the prognosis of rhinopharyngeal
keratinizing squamous cell carcinomas (KS) was worse than
that of non-keratinizing (NK) or undifferentiated (UD)
forms, the 5-year survival rate of our G2 carcinomas was
40% and that of G3 was 52%. The differences however are
not statistically significant. But in our limited series all the
cases were G2 or G3 carcinomas and also the above-
mentioned Authors did not find significative differences
between NK and UD survivals.
The survival rate of our T4 tumours was lower than that
of TI, T2, T3, even though not statistically significant. Also
other Authors (Fletcher, 1973; Crissman et al., 1984; Wolf et
al., 1984; Moore et al., 1986) have indicated the limited
predictive value of the surface diameter in most oral cancers,
especially in those of intermediate size (Moore et al., 1986).
In our series the 64% of the carcinomas were T2 and T3;
moreover the size of the tumour, when clinically evaluated
like as in our cases, lumps the biologically aggressive with the
indolent tumours (Moore et al., 1986).
We did not find significant association between N status
and outcome, even though the 5 year-survival rate of NO
carcinomas was higher than that of N3 cases (52% vs 30%).
This may be due to the relatively low number of Ni and N2
carcinomas and to the lack ofpathologic staging of the cases.
In fact the clinical evaluation of nodal spread is often erron-
eous (Sako et al., 1964) and mixes reactive with metastatic
lymph node enlargement (Moore et al., 1986).
The results concerning the diagnostic and prognostic value
of AgNOR staining are still conflicting, as a variable degree
of overlapping AgNOR has been found in benign and malig-
nant tumours (Nairn et al., 1988; Cronin et al., 1989; Giri et
al., 1989; Howat et al., 1989; McNicol et al., 1989; Ooms et
al., 1989; Hansen & Ostergard, 1990) and no prognostic
significance was observed in embryonal rhabdomyosarcoma
(Egan et al., 1988a), thick cutaneous malignant melanoma
(Howat et al., 1988) and rectal adenocarcinoma (Griffiths et
al., 1989). However, our findings indicate that at least for
pharyngeal carcinomas the AgNOR counts offer a convincing
evidence of their prognostic value.
More controlled and standardised technical procedures and
new analysis methods could improve AgNOR staining and
favour its diffusion as a diagnostic and prognostic tool.
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